Antineoplastic Agents Flashcards

(67 cards)

1
Q

Antimetabolites

A

= *Structural Analogs of Nucleosides of their Precursors
(Except Hydroxyurea)

  • Function Either By:
    (1) Inhibiting Enzymes that MAKE Nucleosides

(2) Incorporation INTO Nucleic Acids
(Inhibition of DNA and RNA Synthesis;
Disruption of RNA Synthesis/ Processing/ Function)

*Cell-Cycle Specific:
=> *Primarily Function @ G1 and/or S Phase of Cell Cycle

(G1 = preparing building blocks for DNA synthesis)

Resistance:
*Are NOT Substrates for the MDR Mechanism generally

Major Classes:

1) Folate Analogs:
_*Methotrexate (MTX)

2) Pyrimidine Analogs:
_5-Fluorouracil
_
Cytosine Arabinoside

3) Purine Analogs:
_6-Mercaptopurine
_
6Thioguanine

4) “Other”: *Hydroxyurea
_Inhibits Ribonucleotide Reductase
_Generally only used in Combination or as a Radiation Sensitizer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

*Methotrexate (MTX)

A

Folate Antimetabolites

1) *Mechanism of Action:
= *Inhibits Dihydrofolate Reductase

2) *Inhibiting Purine, Pyrimidine, and Amino Acid Synthesis
3) *Polyglutamylated form is the *More Active Metabolite.

4) *Selectivity:
=> Formation and *Retention of Polyglutamate Derivatives in Tumor Cells

5) Uses:
(i) *Acute Leukemias (extremely effective)
(ii) *Choriocarcinomas
(Both of these are very rapidly dividing cancer, hence why the drug is very effective.)

6) Toxicity:
(i) *Myelosuppression
=> *Can be Reduced with *Leucovorin (Folinic Acid) “Rescue”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

*5-Fluorouracil (5-FU)

A

Pyrimidine Antimetabolite

Mechanism:
(1) *Inhibits Thymidylate Synthetase (TS)
(when converted to 5-FdUMP)

(2) *Incorporates into DNA and RNA
(when converted to FdUTP and FUTP)

*Leucovorin Enhances Activity by promoting binding.

Uses:

(1) *Solid Tumors: *GI, *Mainly *Colon; Breast
(2) *Topical: *Skin Warts and *Skin Lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cytosine Arabinoside (Ara-C)

A

Pyrimidine Antimetabolite

Mechanism:
1) *Incorporates into DNA via *Competition with *dCTP
(Deoxycytidine)

2) *Inhibits DNA Synthesis

Use: *Potent Anti-Leukemic
(e.g. AML: Acute Myeloblastic Leukemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

6-Mercaptopurine

A

Purine Antimetabolite

Mechanism: *Inhibits DNA and Purine Synthesis

Uses:

1) Leukemias
2) Lymphomas

Toxicity:

1) *Pancreatitis
2) *Hepatic Dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

6-Thioguanine

A

Purine Antimetabolite

Mechanism: *Inhibits DNA and Purine Synthesis

Uses:

1) Leukemias
2) Lymphomas

Toxicity:

1) *Pancreatitis
2) *Hepatic Dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hydroxyurea

A

Analog of Urea

Mechanism:
1) *Inhibits Ribonucleotide Reductase
(enzyme for conversion of ribonucleotides to deoxyribonucleotides)

2) *Inhibits DNA Synthesis

Uses:

1) Radiation Sensitization
2) Leukemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclophosphamide

A

Alkylating Agents:
_Not Cell-cycle Specific
_
Not Substrates for MDR Pump

1) Mustards: Nitrogen Mustards:
(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

2) Nitrosureas:
(i) *Carmustine (BCNU)
(ii) *Lomustine (CCNU)
(iii) Streptozotocin

3) Triazenes: *Temozolomide

________________________

Nitrogen and Sulfur Mustards:
=> Related to Mustard Gas.

**Nitrogen Mustards contain a *BischloroethylAMINE Group

(Sulfur mustards contain a bischloroethylsulfide group)

Mustards: Nitrogen Mustards:

(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

Mechanism:

1) *Alkylates DNA (Cross-links DNA)
2) Inhibits DNA Synthesis

Resistance:
1) *Increased GSH/GSH Metabolic Enzymes
(GSH = Glutathione)

2) Increased Alkyltransferase Repair

Uses:
1) *CNS Tumors (*Nitrosureas)
2) Varies by Drug 
(lymphomas, leukemias, 
solid: breast, lung, ovarian)
Toxicity:
1) *Myelosuppression
2) *Secondary Neoplasias
3) *Hemorrhagic Cystitis
(cyclophosphamide metabolite; contains tear gas)

________________________

Nitrosureas

**Cross the BBB: **Used for Primary Brain Tumors!!

Nitrosureas:

1) *Carmustine (BCNU)
2) *Lomustine (CCNU)

3) Streptozotocin:
_Sugar group confers High Affinity for Pancreas.
=> *Tumors @ Islets of Langerhans (Pancreas)

________________________

Triazenes: *Temozolomide

Crosses BBB.

Uses:
_Gliomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Carmustine (BCNU)

A

Alkylating Agents:
_Not Cell-cycle Specific
_
Not Substrates for MDR Pump

1) Mustards: Nitrogen Mustards:
(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

2) Nitrosureas:
(i) *Carmustine (BCNU)
(ii) *Lomustine (CCNU)
(iii) Streptozotocin

3) Triazenes: *Temozolomide

________________________

Nitrogen and Sulfur Mustards:
=> Related to Mustard Gas.

**Nitrogen Mustards contain a *BischloroethylAMINE Group

(Sulfur mustards contain a bischloroethylsulfide group)

Mustards: Nitrogen Mustards:

(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

Mechanism:

1) *Alkylates DNA (Cross-links DNA)
2) Inhibits DNA Synthesis

Resistance:
1) *Increased GSH/GSH Metabolic Enzymes
(GSH = Glutathione)

2) Increased Alkyltransferase Repair

Uses:
1) *CNS Tumors (*Nitrosureas)
2) Varies by Drug 
(lymphomas, leukemias, 
solid: breast, lung, ovarian)
Toxicity:
1) *Myelosuppression
2) *Secondary Neoplasias
3) *Hemorrhagic Cystitis
(cyclophosphamide metabolite; contains tear gas)

________________________

Nitrosureas

**Cross the BBB: **Used for Primary Brain Tumors!!

Nitrosureas:

1) *Carmustine (BCNU)
2) *Lomustine (CCNU)

3) Streptozotocin:
_Sugar group confers High Affinity for Pancreas.
=> *Tumors @ Islets of Langerhans (Pancreas)

________________________

Triazenes: *Temozolomide

Crosses BBB.

Uses:
_Gliomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lomustine (CCNU)

A

Alkylating Agents:
_Not Cell-cycle Specific
_
Not Substrates for MDR Pump

1) Mustards: Nitrogen Mustards:
(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

2) Nitrosureas:
(i) *Carmustine (BCNU)
(ii) *Lomustine (CCNU)
(iii) Streptozotocin

3) Triazenes: *Temozolomide

________________________

Nitrogen and Sulfur Mustards:
=> Related to Mustard Gas.

**Nitrogen Mustards contain a *BischloroethylAMINE Group

(Sulfur mustards contain a bischloroethylsulfide group)

Mustards: Nitrogen Mustards:

(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

Mechanism:

1) *Alkylates DNA (Cross-links DNA)
2) Inhibits DNA Synthesis

Resistance:
1) *Increased GSH/GSH Metabolic Enzymes
(GSH = Glutathione)

2) Increased Alkyltransferase Repair

Uses:
1) *CNS Tumors (*Nitrosureas)
2) Varies by Drug 
(lymphomas, leukemias, 
solid: breast, lung, ovarian)
Toxicity:
1) *Myelosuppression
2) *Secondary Neoplasias
3) *Hemorrhagic Cystitis
(cyclophosphamide metabolite; contains tear gas)

________________________

Nitrosureas

**Cross the BBB: **Used for Primary Brain Tumors!!

Nitrosureas:

1) *Carmustine (BCNU)
2) *Lomustine (CCNU)

3) Streptozotocin:
_Sugar group confers High Affinity for Pancreas.
=> *Tumors @ Islets of Langerhans (Pancreas)

________________________

Triazenes: *Temozolomide

Crosses BBB.

Uses:
_Gliomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Temozolomide

A

Alkylating Agents:
_Not Cell-cycle Specific
_
Not Substrates for MDR Pump

1) Mustards: Nitrogen Mustards:
(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

2) Nitrosureas:
(i) *Carmustine (BCNU)
(ii) *Lomustine (CCNU)
(iii) Streptozotocin

3) Triazenes: *Temozolomide

________________________

Nitrogen and Sulfur Mustards:
=> Related to Mustard Gas.

**Nitrogen Mustards contain a *BischloroethylAMINE Group

(Sulfur mustards contain a bischloroethylsulfide group)

Mustards: Nitrogen Mustards:

(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

Mechanism:

1) *Alkylates DNA (Cross-links DNA)
2) Inhibits DNA Synthesis

Resistance:
1) *Increased GSH/GSH Metabolic Enzymes
(GSH = Glutathione)

2) Increased Alkyltransferase Repair

Uses:
1) *CNS Tumors (*Nitrosureas)
2) Varies by Drug 
(lymphomas, leukemias, 
solid: breast, lung, ovarian)
Toxicity:
1) *Myelosuppression
2) *Secondary Neoplasias
3) *Hemorrhagic Cystitis
(cyclophosphamide metabolite; contains tear gas)

________________________

Nitrosureas

**Cross the BBB: **Used for Primary Brain Tumors!!

Nitrosureas:

1) *Carmustine (BCNU)
2) *Lomustine (CCNU)

3) Streptozotocin:
_Sugar group confers High Affinity for Pancreas.
=> *Tumors @ Islets of Langerhans (Pancreas)

________________________

Triazenes: *Temozolomide

Crosses BBB.

Uses:
_Gliomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Streptozotocin

A

Alkylating Agents:
_Not Cell-cycle Specific
_
Not Substrates for MDR Pump

1) Mustards: Nitrogen Mustards:
(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

2) Nitrosureas:
(i) *Carmustine (BCNU)
(ii) *Lomustine (CCNU)
(iii) Streptozotocin

3) Triazenes: *Temozolomide

________________________

Nitrogen and Sulfur Mustards:
=> Related to Mustard Gas.

**Nitrogen Mustards contain a *BischloroethylAMINE Group

(Sulfur mustards contain a bischloroethylsulfide group)

Mustards: Nitrogen Mustards:

(i) **Cyclophosphamide
(ii) *Melphalan
(iii) *Chlorambucil

Mechanism:

1) *Alkylates DNA (Cross-links DNA)
2) Inhibits DNA Synthesis

Resistance:
1) *Increased GSH/GSH Metabolic Enzymes
(GSH = Glutathione)

2) Increased Alkyltransferase Repair

Uses:
1) *CNS Tumors (*Nitrosureas)
2) Varies by Drug 
(lymphomas, leukemias, 
solid: breast, lung, ovarian)
Toxicity:
1) *Myelosuppression
2) *Secondary Neoplasias
3) *Hemorrhagic Cystitis
(cyclophosphamide metabolite; contains tear gas)

________________________

Nitrosureas

**Cross the BBB: **Used for Primary Brain Tumors!!

Nitrosureas:

1) *Carmustine (BCNU)
2) *Lomustine (CCNU)

3) Streptozotocin:
_Sugar group confers High Affinity for Pancreas.
=> *Tumors @ Islets of Langerhans (Pancreas)

________________________

Triazenes: *Temozolomide

Crosses BBB.

Uses:
_Gliomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cisplatin

A

Platinum Compounds

Alkylating-Like Agents

1) **Cisplatin
2) *Oxaliplatin

  • Not Cell-cycle Specific
  • Not Substrates MDR Pump

Mechanism:
1) *Form Intra-strand and Inter-strand DNA Cross-Links
=> Results in DNA Breaks
2) *Inhibits DNA Synthesis

(Only Cis form is active; trans platinum is inactive.)

(Activated when in contact with water.

(Was accidentally discovered to block bacterial cell division.)

Resistance:

1) *Increased GSH/GSH-Metabolic Enzymes
2) *Increased DNA Repair

Uses: *Solid Tumors:
1) *Testicular Cancers

Toxicity:

1) *Nephrotoxicity
2) *Ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oxaliplatin

A

Platinum Compounds

Alkylating-Like Agents

1) **Cisplatin
2) *Oxaliplatin

  • Not Cell-cycle Specific
  • Not Substrates MDR Pump

Mechanism:
1) *Form Intra-strand and Inter-strand DNA Cross-Links
=> Results in DNA Breaks
2) *Inhibits DNA Synthesis

(Only Cis form is active; trans platinum is inactive.)

(Activated when in contact with water.

(Was accidentally discovered to block bacterial cell division.)

Resistance:

1) *Increased GSH/GSH-Metabolic Enzymes
2) *Increased DNA Repair

Uses: *Solid Tumors:
1) *Testicular Cancers

Toxicity:

1) *Nephrotoxicity
2) *Ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mitoxantrone

A

DNA-Interacting Antibiotics

(Multi-ring Anthracyclines)

*Not Cell-cycle Specific.
_But G phases (Growth) is More Susceptible.

Rubicins:

(i) *Doxorubicin
(ii) *Daunorubicin

Mechanism:
1) *Intercalate into DNA
(Disrupts DNA and RNA synthesis)

2) *Topoisomerase II Inhibition
(Due to distortion of double-helix: DNA strand breaks and DNA-protein cross-links)

3) *Generate ROS

Resistance:
=> *Are Substrates for MDR Pump!
(Due to planar structure)

Toxicity:  (Ruby Red Cardiotox!)
*Cardiotoxicity:
1) *Acute: Arrhythmias
2) *Chronic: CHF
(b/c Heart is a major producer of ROS anyway)

____________________

*Mitoxantrone:
_Similar Structure and Mechanism to Anthracyclines

_However, *Reduced Cardiotoxicity!!

=> Due to *Reduced ROS Formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Doxorubicin

A

DNA-Interacting Antibiotics

(Multi-ring Anthracyclines)

*Not Cell-cycle Specific.
_But G phases (Growth) is More Susceptible.

Rubicins:

(i) *Doxorubicin
(ii) *Daunorubicin

Mechanism:
1) *Intercalate into DNA
(Disrupts DNA and RNA synthesis)

2) *Topoisomerase II Inhibition
(Due to distortion of double-helix: DNA strand breaks and DNA-protein cross-links)

3) *Generate ROS

Resistance:
=> *Are Substrates for MDR Pump!
(Due to planar structure)

Toxicity:  (Ruby Red Cardiotox!)
*Cardiotoxicity:
1) *Acute: Arrhythmias
2) *Chronic: CHF
(b/c Heart is a major producer of ROS anyway)

____________________

*Mitoxantrone:
_Similar Structure and Mechanism to Anthracyclines

_However, *Reduced Cardiotoxicity!!

=> Due to *Reduced ROS Formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Daunorubicin

A

DNA-Interacting Antibiotics

(Multi-ring Anthracyclines)

*Not Cell-cycle Specific.
_But G phases (Growth) is More Susceptible.

Rubicins:

(i) *Doxorubicin
(ii) *Daunorubicin

Mechanism:
1) *Intercalate into DNA
(Disrupts DNA and RNA synthesis)

2) *Topoisomerase II Inhibition
(Due to distortion of double-helix: DNA strand breaks and DNA-protein cross-links)

3) *Generate ROS

Resistance:
=> *Are Substrates for MDR Pump!
(Due to planar structure)

Toxicity:  (Ruby Red Cardiotox!)
*Cardiotoxicity:
1) *Acute: Arrhythmias
2) *Chronic: CHF
(b/c Heart is a major producer of ROS anyway)

____________________

*Mitoxantrone:
_Similar Structure and Mechanism to Anthracyclines

_However, *Reduced Cardiotoxicity!!

=> Due to *Reduced ROS Formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Plant (Natural) Products

A

Microtubule Inhibitors:
(“Spindle Poisons”)

1) Stabilizers: Taxanes:
_
Paclitaxel (Taxol)

2) Destabilizers: Vinca Alkaloids:
_
Vincristine (Oncovin)
_*Vinblastine (Velban)

Microtubule Inhibitors
(“Spindle Poisons”)
_Active During Mitosis, where they perturb the Mitotic Spindle and Disrupt Proper Chromosome Segregation

____________________

Topoisomerase Inhibitors:

1) Topoisomerase II Inhibitors:
_*Epipodophyllotoxins:
(i) *Etoposide *(VM-16)
(ii) *Teniposide *(VM-26)

2) Topoisomerase I Inhibitors:
_*Camptothecins: *Irinotecan

  • Topoisomerases Unwind Tangled DNA by cutting one strand so another can pass through the break:
    (1) Topo I: Relaxes Supercoils Ahead of DNA replication fork.
    (2) Topo II: Allows Daughter strands to pass THROUGH one another.
  • Topoisomerase Inhibitors Stabilize the DNA-Topo Intermediate in the Cut state, Leading to DNA Breaks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Paclitaxel

A

Taxanes

Source: Yew Tree Bark
(FSU total synthesis: Taxol)

Microtubule Inhibitors
(“Spindle Poisons”)

*Paclitaxel (Taxol)

Mechanism:
*Stabilizes Microtubule;
= *Prevents Tubulin Depolymerization
= *Inhibits Microtubule Disassembly

Uses: *Solid Tumors
(ovarian, breast, lung)

Resistance:
*Substrate for MDR Pump

Toxicity:

1) *Peripheral Neuropathy
2) Cumulative Myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vinblastine

A

Vinca Alkaloids

(Looks Like Pacman eating Ghost)
(Complex Plant Derivatives)

Microtubule Inhibitors
(“Spindle Poisons”)

  • Specificity: *M Phase (Mitosis).
  • Vinblastine, *Vincristine

Mechanism:

1) *Destabilizes Microtubules
2) *Mitotic Arrest

Resistance: *MDR Efflux Pumps

Toxicity:
1) Neurotoxicity (Vincristine)
(*Muscle Weakness, *Peripheral Neuropathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vincristine

A

Vinca Alkaloids

(Looks Like Pacman eating Ghost)
(Complex Plant Derivatives)

Microtubule Inhibitors
(“Spindle Poisons”)

  • Specificity: *M Phase (Mitosis).
  • Vinblastine, *Vincristine

Mechanism:

1) *Destabilizes Microtubules
2) *Mitotic Arrest

Resistance: *MDR Efflux Pumps

Toxicity:
1) Neurotoxicity (Vincristine)
(*Muscle Weakness, *Peripheral Neuropathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Etoposide

A

Epipodophyllotoxins

(Derived from Mayapple / American Mandrake)

Topoisomerase II Inhibitor

1) *Etoposide *(VP-16)
2) *Teniposide *(VM-26

Mechanism:

1) *Stabilizes Topo II-DNA Intermediate,
2) *Leading to DNA Breaks

(Mechanism and structure similar to Anthracyclines; S and G2 phases most sensitive)

Resistance:
1) *MDR Pump

2) *Decreased or *Mutant Topo II

3) *p53 Mutation
(p53 mediates response to DNA damage)

Toxicity:

1) *Leukopenia *(Dose-Limiting)
2) *Hepatotoxicity *(High-Dose)

____________________

  • Topoisomerases Unwind Tangled DNA by cutting one strand so another can pass through the break:
    (1) Topo I: Relaxes Supercoils Ahead of DNA replication fork.
    (2) Topo II: Allows Daughter strands to pass THROUGH one another.
  • Topoisomerase Inhibitors Stabilize the DNA-Topo Intermediate in the Cut state, Leading to DNA Breaks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Teniposide

A

Epipodophyllotoxins

(Derived from Mayapple / American Mandrake)

Topoisomerase II Inhibitor

1) *Etoposide *(VP-16)
2) *Teniposide *(VM-26

Mechanism:

1) *Stabilizes Topo II-DNA Intermediate,
2) *Leading to DNA Breaks

(Mechanism and structure similar to Anthracyclines; S and G2 phases most sensitive)

Resistance:
1) *MDR Pump

2) *Decreased or *Mutant Topo II

3) *p53 Mutation
(p53 mediates response to DNA damage)

Toxicity:

1) *Leukopenia *(Dose-Limiting)
2) *Hepatotoxicity *(High-Dose)

____________________

  • Topoisomerases Unwind Tangled DNA by cutting one strand so another can pass through the break:
    (1) Topo I: Relaxes Supercoils Ahead of DNA replication fork.
    (2) Topo II: Allows Daughter strands to pass THROUGH one another.
  • Topoisomerase Inhibitors Stabilize the DNA-Topo Intermediate in the Cut state, Leading to DNA Breaks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Irinotecan

A

Camptothecins

(Derived from Happy Tree)

Topoisomerase I Inhibitor

*Irinotecan

Mechanism:
1) *Stabilizes Topo I-DNA Intermediate

Resistance:

1) Reduced levels or Altered Affinity of Topo I (Mutant)
2) Weak Substrate for MDR Pump

Uses: *Solid Tumors
(ovarian, colon, small cell lung cancers: SCLC)

____________________

  • Topoisomerases Unwind Tangled DNA by cutting one strand so another can pass through the break:
    (1) Topo I: Relaxes Supercoils Ahead of DNA replication fork.
    (2) Topo II: Allows Daughter strands to pass THROUGH one another.
  • Topoisomerase Inhibitors Stabilize the DNA-Topo Intermediate in the Cut state, Leading to DNA Breaks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Hormone-Targeted Chemotherapy
Goal: *Turn OFF Hormone Signaling Uses: 1) *Endometrial 2) *Breast 3) *Prostate 4) (Sometimes Lung Cancer b/c Estrogen Receptor is expressed in Lung) Approaches: 1) *Compete with Endogenous Hormone for Receptor Binding 2) *Block Production of Endogenous Hormone **Toxicities are Much Milder than Other Chemotherapeutics _B/c Not actually Killing the cells
26
Flutamide
Anti-Androgenic Agents 1) Anti-Androgens: *Flutamide Mechanism: *Competitive Antagonist of Androgens Use: *Prostate Cancer 2) LHRH Agonists: *Leuprolide Mechanism: *Inhibits Androgen Release via Downregulation (with chronic administration) Use: *Prostate Cancer (and GnRH antagonist)
27
Leuprolide
Anti-Androgenic Agents 1) Anti-Androgens: *Flutamide Mechanism: *Competitive Antagonist of Androgens Use: *Prostate Cancer 2) LHRH Agonists: *Leuprolide Mechanism: *Inhibits Androgen Release via Downregulation (with chronic administration) Use: *Prostate Cancer (and GnRH antagonist)
28
Tamoxifen
Anti-Estrogenic Agents 1) Anti-Estrogens: *Tamoxifen Mechanism: *Competitive Antagonist of Estrogen Use: _Prevents or Slows Growth of Estrogen-Dependent Tumors: *Breast Cancer 2) Aromatase Inhibitors: *Anastrazole Mechanism: 1) *Inhibits Aromatase, 2) *Blocking Estrogen Synthesis Use: _Breast Cancer in Post-Menopausal Women
29
Anastrazole
Anti-Estrogenic Agents 1) Anti-Estrogens: *Tamoxifen Mechanism: *Competitive Antagonist of Estrogen Use: _Prevents or Slows Growth of Estrogen-Dependent Tumors: *Breast Cancer 2) Aromatase Inhibitors: *Anastrazole Mechanism: 1) *Inhibits Aromatase, 2) *Blocking Estrogen Synthesis Use: _Breast Cancer in Post-Menopausal Women
30
Corticosteroids | Glucocorticoids
Mechanism: _*Lyse Malignant T lymphocytes Use: 1) *Lymphomas 2) *Acute Lymphocytic Leukemia
31
Bleomycin
Miscellaneous Agent Mechanism: *Breaks DNA via *Free Radicals Toxicity: _*Minimal Marrow Toxicity
32
Aspariginase
Miscellaneous Agent Mechanism: _*Inhibits Protein Synthesis Resistance: _*Increase Asparagine Synthetase Activity in Tumor cell Use: *Childhood Acute Leukemia Toxicity: *Hypersensitivity Reactions
33
Targeted Therapies of Cancer: "New Wave"
**Target Specific Molecular Pathways or Mediators of the Malignant Phenotype. Efficacy: _*More Effective than conventional therapies, _*But only in cases where target is a prominent factor in the disease Toxicities: _*Less than conventional therapies _*Infusion Reactions are common for most IV agents. 1) Tyrosine Kinase Inhibitors (-Tinibs) 2) Disruptors of Gene Expression, Protein Translation, Proteolysis 3) Monoclonal Antibodies (-Mabs) 4) Cytokines and Immunomodulators 5) Differentiating Agents 6) Other
34
Imatinib
Tyrosine Kinase Inhibitors = Analogs of ATP Designed Against Kinases that Activate Pro-Growth, Pro-Survival Pathways. Use is guided by known frequent Deregulation of a Receptor-Pathway in a given cancer. Mechanisms: 1) *Promote Apoptosis 2) *Inhibit Growth Factors 3) *Inhibit Angiogenesis 4) *Inhibit Proliferation Usually Given *p.o. (orally) Adverse Effects: 1) *Skin and *Mucosal Effects 2) *Fatigue ___________________ 1) *Imatinib: Mechanism: *Inhibits Abl Kinase *(ABL-BCR Fusion Gene) (Philadelphia Chromosome) Use: *Drug of Choice!: *Chronic Myelogenous Leukemia ___________________ 2) Gefetinib: Mechanism: *Inhibits EGFR (Epidermal Growth Factor Receptor) Use: *Oral Treatment of NSCLC (Non-small cell lung cancer) (Most effective in Never-Smoker Females and Asians) ___________________ 3) Lapatinib: Mechanism: *Inhibits HER-2 Use: *Advanced/Metastatic Breast Cancer ___________________ 4) Sunitinib (not bold this yr) Mechanism: Blocks VEGFR (Vascular Endothelial Growth Factor Receptor) Use: Renal Cancer Not as selective for desired kinases (good or bad?)
35
Gefetinib
Tyrosine Kinase Inhibitors = Analogs of ATP Designed Against Kinases that Activate Pro-Growth, Pro-Survival Pathways. Use is guided by known frequent Deregulation of a Receptor-Pathway in a given cancer. Mechanisms: 1) *Promote Apoptosis 2) *Inhibit Growth Factors 3) *Inhibit Angiogenesis 4) *Inhibit Proliferation Usually Given *p.o. (orally) Adverse Effects: 1) *Skin and *Mucosal Effects 2) *Fatigue ___________________ 1) *Imatinib: Mechanism: *Inhibits Abl Kinase *(ABL-BCR Fusion Gene) (Philadelphia Chromosome) Use: *Drug of Choice!: *Chronic Myelogenous Leukemia ___________________ 2) Gefetinib: Mechanism: *Inhibits EGFR (Epidermal Growth Factor Receptor) Use: *Oral Treatment of NSCLC (Non-small cell lung cancer) (Most effective in Never-Smoker Females and Asians) ___________________ 3) Lapatinib: Mechanism: *Inhibits HER-2 Use: *Advanced/Metastatic Breast Cancer ___________________ 4) Sunitinib (not bold this yr) Mechanism: Blocks VEGFR (Vascular Endothelial Growth Factor Receptor) Use: Renal Cancer Not as selective for desired kinases (good or bad?)
36
Lapatinib
Tyrosine Kinase Inhibitors = Analogs of ATP Designed Against Kinases that Activate Pro-Growth, Pro-Survival Pathways. Use is guided by known frequent Deregulation of a Receptor-Pathway in a given cancer. Mechanisms: 1) *Promote Apoptosis 2) *Inhibit Growth Factors 3) *Inhibit Angiogenesis 4) *Inhibit Proliferation Usually Given *p.o. (orally) Adverse Effects: 1) *Skin and *Mucosal Effects 2) *Fatigue ___________________ 1) *Imatinib: Mechanism: *Inhibits Abl Kinase *(ABL-BCR Fusion Gene) (Philadelphia Chromosome) Use: *Drug of Choice!: *Chronic Myelogenous Leukemia ___________________ 2) Gefetinib: Mechanism: *Inhibits EGFR (Epidermal Growth Factor Receptor) Use: *Oral Treatment of NSCLC (Non-small cell lung cancer) (Most effective in Never-Smoker Females and Asians) ___________________ 3) Lapatinib: Mechanism: *Inhibits HER-2 Use: *Advanced/Metastatic Breast Cancer ___________________ 4) Sunitinib (not bold this yr) Mechanism: Blocks VEGFR (Vascular Endothelial Growth Factor Receptor) Use: Renal Cancer Not as selective for desired kinases (good or bad?)
37
Sunitinib
Tyrosine Kinase Inhibitors = Analogs of ATP Designed Against Kinases that Activate Pro-Growth, Pro-Survival Pathways. Use is guided by known frequent Deregulation of a Receptor-Pathway in a given cancer. Mechanisms: 1) *Promote Apoptosis 2) *Inhibit Growth Factors 3) *Inhibit Angiogenesis 4) *Inhibit Proliferation Usually Given *p.o. (orally) Adverse Effects: 1) *Skin and *Mucosal Effects 2) *Fatigue ___________________ 1) *Imatinib: Mechanism: *Inhibits Abl Kinase *(ABL-BCR Fusion Gene) (Philadelphia Chromosome) Use: *Drug of Choice!: *Chronic Myelogenous Leukemia ___________________ 2) Gefetinib: Mechanism: *Inhibits EGFR (Epidermal Growth Factor Receptor) Use: *Oral Treatment of NSCLC (Non-small cell lung cancer) (Most effective in Never-Smoker Females and Asians) ___________________ 3) Lapatinib: Mechanism: *Inhibits HER-2 Use: *Advanced/Metastatic Breast Cancer ___________________ 4) Sunitinib (not bold this yr) Mechanism: Blocks VEGFR (Vascular Endothelial Growth Factor Receptor) Use: Renal Cancer Not as selective for desired kinases (good or bad?)
38
HDAC Inhibitors
Transcription, Translation, and Proteolysis Disruptors HDAC Inhibitors: _*Prevent Histone Deacetylation Rapamycins (Sirolimus): 1) *Block New Protein Synthesis 2) *Stimulate Autophagy *Proteasome Inhibitors: _*Bortezomib _*Block Protein Turnover by the Proteasome; Induce Apoptosis Use: *Multiple Myeloma (1st line)
39
Sirolimus
Transcription, Translation, and Proteolysis Disruptors HDAC Inhibitors: _*Prevent Histone Deacetylation Rapamycins (Sirolimus): 1) *Block New Protein Synthesis 2) *Stimulate Autophagy *Proteasome Inhibitors: _*Bortezomib _*Block Protein Turnover by the Proteasome; Induce Apoptosis Use: *Multiple Myeloma (1st line)
40
Bortezomib
Transcription, Translation, and Proteolysis Disruptors HDAC Inhibitors: _*Prevent Histone Deacetylation Rapamycins (Sirolimus): 1) *Block New Protein Synthesis 2) *Stimulate Autophagy *Proteasome Inhibitors: _*Bortezomib _*Block Protein Turnover by the Proteasome; Induce Apoptosis Use: *Multiple Myeloma (1st line)
41
Rituximab
Monoclonal Antibodies *All Must be Given by Infusion *Can Cause Infusion Reactions: _*Rash, *Edema, *Hypotension, *Bronchospasms; _*Rarely, Anaphylaxis 1) *Rituximab: _Antigen: *CD20 _Use: *B cell Lymphoma _Mechanism: ADCC 2) *Alemtuzumab: Antigen: *CD52 Use: *T cell Lymphoma Mechanism: ADCC 3) *Trastuzumab: Antigen: *HER-2/Neu Tyrosine Kinase Use: *Breast Cancer Mechanism: Block Receptor and Deliver Toxic species 4) *Cetuximab: Antigen: *EGFR Tyrosine Kinase Use: *Colorectal Mechanism: Block Receptor ``` 5) *Bevacizumab: Antigen: *VEGF (Reduces Angiogenesis) Use: *Colorectal Cancer Mechanism: Absorb Ligand ``` ___________________ Mechanisms: 1) Recruit immune cells to Trigger *Antibody-Dependent Cell-Mediated Toxicity (ADCC): _Rituximab _Alemtuzumab 2) *Absorb a Ligand for a Receptor: _Bevacizumab 3) *Block Activation of a Receptor: _Trastuzumab _Cetuximab 4) *Deliver a Toxic Species to Cancer Cells: _Trastuzumab-emtansine
42
Alemtuzumab
Monoclonal Antibodies *All Must be Given by Infusion *Can Cause Infusion Reactions: _*Rash, *Edema, *Hypotension, *Bronchospasms; _*Rarely, Anaphylaxis 1) *Rituximab: _Antigen: *CD20 _Use: *B cell Lymphoma _Mechanism: ADCC 2) *Alemtuzumab: Antigen: *CD52 Use: *T cell Lymphoma Mechanism: ADCC 3) *Trastuzumab: Antigen: *HER-2/Neu Tyrosine Kinase Use: *Breast Cancer Mechanism: Block Receptor and Deliver Toxic species 4) *Cetuximab: Antigen: *EGFR Tyrosine Kinase Use: *Colorectal Mechanism: Block Receptor ``` 5) *Bevacizumab: Antigen: *VEGF (Reduces Angiogenesis) Use: *Colorectal Cancer Mechanism: Absorb Ligand ``` ___________________ Mechanisms: 1) Recruit immune cells to Trigger *Antibody-Dependent Cell-Mediated Toxicity (ADCC): _Rituximab _Alemtuzumab 2) *Absorb a Ligand for a Receptor: _Bevacizumab 3) *Block Activation of a Receptor: _Trastuzumab _Cetuximab 4) *Deliver a Toxic Species to Cancer Cells: _Trastuzumab-emtansine
43
Trastuzumab
Monoclonal Antibodies *All Must be Given by Infusion *Can Cause Infusion Reactions: _*Rash, *Edema, *Hypotension, *Bronchospasms; _*Rarely, Anaphylaxis 1) *Rituximab: _Antigen: *CD20 _Use: *B cell Lymphoma _Mechanism: ADCC 2) *Alemtuzumab: Antigen: *CD52 Use: *T cell Lymphoma Mechanism: ADCC 3) *Trastuzumab: Antigen: *HER-2/Neu Tyrosine Kinase Use: *Breast Cancer Mechanism: Block Receptor and Deliver Toxic species 4) *Cetuximab: Antigen: *EGFR Tyrosine Kinase Use: *Colorectal Mechanism: Block Receptor ``` 5) *Bevacizumab: Antigen: *VEGF (Reduces Angiogenesis) Use: *Colorectal Cancer Mechanism: Absorb Ligand ``` ___________________ Mechanisms: 1) Recruit immune cells to Trigger *Antibody-Dependent Cell-Mediated Toxicity (ADCC): _Rituximab _Alemtuzumab 2) *Absorb a Ligand for a Receptor: _Bevacizumab 3) *Block Activation of a Receptor: _Trastuzumab _Cetuximab 4) *Deliver a Toxic Species to Cancer Cells: _Trastuzumab-emtansine
44
Cetuximab
Monoclonal Antibodies *All Must be Given by Infusion *Can Cause Infusion Reactions: _*Rash, *Edema, *Hypotension, *Bronchospasms; _*Rarely, Anaphylaxis 1) *Rituximab: _Antigen: *CD20 _Use: *B cell Lymphoma _Mechanism: ADCC 2) *Alemtuzumab: Antigen: *CD52 Use: *T cell Lymphoma Mechanism: ADCC 3) *Trastuzumab: Antigen: *HER-2/Neu Tyrosine Kinase Use: *Breast Cancer Mechanism: Block Receptor and Deliver Toxic species 4) *Cetuximab: Antigen: *EGFR Tyrosine Kinase Use: *Colorectal Mechanism: Block Receptor ``` 5) *Bevacizumab: Antigen: *VEGF (Reduces Angiogenesis) Use: *Colorectal Cancer Mechanism: Absorb Ligand ``` ___________________ Mechanisms: 1) Recruit immune cells to Trigger *Antibody-Dependent Cell-Mediated Toxicity (ADCC): _Rituximab _Alemtuzumab 2) *Absorb a Ligand for a Receptor: _Bevacizumab 3) *Block Activation of a Receptor: _Trastuzumab _Cetuximab 4) *Deliver a Toxic Species to Cancer Cells: _Trastuzumab-emtansine
45
Bevacizumab
Monoclonal Antibodies *All Must be Given by Infusion *Can Cause Infusion Reactions: _*Rash, *Edema, *Hypotension, *Bronchospasms; _*Rarely, Anaphylaxis 1) *Rituximab: _Antigen: *CD20 _Use: *B cell Lymphoma _Mechanism: ADCC 2) *Alemtuzumab: Antigen: *CD52 Use: *T cell Lymphoma Mechanism: ADCC 3) *Trastuzumab: Antigen: *HER-2/Neu Tyrosine Kinase Use: *Breast Cancer Mechanism: Block Receptor and Deliver Toxic species 4) *Cetuximab: Antigen: *EGFR Tyrosine Kinase Use: *Colorectal Mechanism: Block Receptor ``` 5) *Bevacizumab: Antigen: *VEGF (Reduces Angiogenesis) Use: *Colorectal Cancer Mechanism: Absorb Ligand ``` ___________________ Mechanisms: 1) Recruit immune cells to Trigger *Antibody-Dependent Cell-Mediated Toxicity (ADCC): _Rituximab _Alemtuzumab 2) *Absorb a Ligand for a Receptor: _Bevacizumab 3) *Block Activation of a Receptor: _Trastuzumab _Cetuximab 4) *Deliver a Toxic Species to Cancer Cells: _Trastuzumab-emtansine
46
Interleukin-2 (IL-2)
Cytokines: *Interleukin-2 (IL-2) Mechanism: => *Produces Tumor-Cytolytic Lymphocytes Uses: 1) *Renal Cell Carcinoma (RCC) 2) *Metastatic Melanoma
47
Colony Stimulating Factors
Differentiating Agents (Inducing Differentiation should stop cancer cells from dividing) Effects: @ Level of Gene Transcription 1) *Colony Stimulating Factors: Mechanism: => Act on Cells @ Various Stages of Hematopoietic Hierarchy Use: => Replenish RBCs suppressed by chemotherapy 2) *Retinoic Acids: (Vitamin A Derivatives) _*Tretinoin (*All trans-retinoic Acid) _*Accutane Rarely used, but effective against Acute Pro-Myelocytic Leukemias (=> Reduce likelihood of transformation into Leukemia)
48
Accutane
Differentiating Agents (Inducing Differentiation should stop cancer cells from dividing) Effects: @ Level of Gene Transcription 1) *Colony Stimulating Factors: Mechanism: => Act on Cells @ Various Stages of Hematopoietic Hierarchy Use: => Replenish RBCs suppressed by chemotherapy 2) *Retinoic Acids: (Vitamin A Derivatives) _*Tretinoin (*All trans-retinoic Acid) _*Accutane Rarely used, but effective against Acute Pro-Myelocytic Leukemias (=> Reduce likelihood of transformation into Leukemia)
49
Cyclosporine
ImmunoSuppressors Calcineurin Inhibitors: 1) Cyclosporine 2) Tacrolimus Mechanism: 1) Blocks Calcineurin; => Blocking Cell Proliferation Uses: 1) Organ Transplant 2) Autoimmune: Rheumatoid Arthritis Toxicity: 1) Nephrotoxic 2) CYP450 Drug Interactions
50
Tacrolimus
ImmunoSuppressors Calcineurin Inhibitors: 1) Cyclosporine 2) Tacrolimus Mechanism: 1) Blocks Calcineurin; => Blocking Cell Proliferation Uses: 1) Organ Transplant 2) Autoimmune: Rheumatoid Arthritis Toxicity: 1) Nephrotoxic 2) CYP450 Drug Interactions
51
Sirolimus | Immuno
ImmunoSuppressors Target of Rapamycin (mTOR) Inhibitors: _Sirolimus Mechanism: 1) Inhibits mTOR; => Blocking Cell Proliferation Uses: 1) Transplant Rejection 2) Reduce Proliferation in Stents Toxicity: 1) CYP450 Drug Interactions 2) Elevated Blood Lipids 3) Risk of Cancer 4) Myelosuppression 5) Risk of Infections
52
Methotrexate | Immuno
ImmunoSuppressors ``` Anti-Proliferative Agents: => Anti-Metabolites: 1) Methotrexate (Folate Analog) 2) Azathioprine (Purine Analog) 3) Mycophenolate Mofetil (Purine Analog) ``` Mechanism: 1) Interfere with Nucleic Acid Synthesis 2) Affects Cellular Immunity More than Humoral Uses: 1) Organ Transplant: *RENAL 2) Some Autoimmune Toxicity: 1) Myelosuppression 2) GI: Nausea, Vomiting
53
Azathioprine
ImmunoSuppressors ``` Anti-Proliferative Agents: => Anti-Metabolites: 1) Methotrexate (Folate Analog) 2) Azathioprine (Purine Analog) 3) Mycophenolate Mofetil (Purine Analog) ``` Mechanism: 1) Interfere with Nucleic Acid Synthesis 2) Affects Cellular Immunity More than Humoral Uses: 1) Organ Transplant: *RENAL 2) Some Autoimmune Toxicity: 1) Myelosuppression 2) GI: Nausea, Vomiting
54
Mycophenolate Mofetil
ImmunoSuppressors ``` Anti-Proliferative Agents: => Anti-Metabolites: 1) Methotrexate (Folate Analog) 2) Azathioprine (Purine Analog) 3) Mycophenolate Mofetil (Purine Analog) ``` Mechanism: 1) Interfere with Nucleic Acid Synthesis 2) Affects Cellular Immunity More than Humoral Uses: 1) Organ Transplant: *RENAL 2) Some Autoimmune Toxicity: 1) Myelosuppression 2) GI: Nausea, Vomiting
55
Cyclophosphamide | Immuno
ImmunoSuppressors Alkylating Agents: 1) Nitrogen Mustards: Cyclophosphamide Mechanism: 1) Alkylates DNA (Cross-Links) => Inhibits DNA Synthesis 2) Humoral Immunity Affected More than Cellular Immunity Uses: 1) Bone Marrow Transplant 2) Autoimmune Toxicity: 1) Myelosuppression 2) Secondary Neoplasias 3) Hemorrhagic Cystitis 4) GI: Nausea, Vomiting
56
Prednisone
ImmunoSuppressors Corticosteroids (Glucocorticoids): 1) Prednisone 2) Hydrocortisone 3) Dexamethasone Mechanism: 1) Reduce T Cell Function, 2) Reduce Chemotaxis, 3) Inhibit Production of Inflammatory Mediators Uses: 1) Autoimmune 2) Inflammatory Diseases 3) Transplant Adjunct ``` Toxicity: 1) Fat Deposition Changes: _Moon Face, Buffalo Hump 2) Diabetes, Hyperglycemia 3) Psychosis 4) Risk of Infection 5) (Discontinue Slowly to Avoid Adrenal Insufficiency ```
57
Hydrocortisone
ImmunoSuppressors Corticosteroids (Glucocorticoids): 1) Prednisone 2) Hydrocortisone 3) Dexamethasone Mechanism: 1) Reduce T Cell Function, 2) Reduce Chemotaxis, 3) Inhibit Production of Inflammatory Mediators Uses: 1) Autoimmune 2) Inflammatory Diseases 3) Transplant Adjunct ``` Toxicity: 1) Fat Deposition Changes: _Moon Face, Buffalo Hump 2) Diabetes, Hyperglycemia 3) Psychosis 4) Risk of Infection 5) (Discontinue Slowly to Avoid Adrenal Insufficiency ```
58
Dexamethasone
ImmunoSuppressors Corticosteroids (Glucocorticoids): 1) Prednisone 2) Hydrocortisone 3) Dexamethasone Mechanism: 1) Reduce T Cell Function, 2) Reduce Chemotaxis, 3) Inhibit Production of Inflammatory Mediators Uses: 1) Autoimmune 2) Inflammatory Diseases 3) Transplant Adjunct ``` Toxicity: 1) Fat Deposition Changes: _Moon Face, Buffalo Hump 2) Diabetes, Hyperglycemia 3) Psychosis 4) Risk of Infection 5) (Discontinue Slowly to Avoid Adrenal Insufficiency ```
59
Rh0 Antibody
ImmunoSuppressors Uses: => Prevents Hemolytic Disease of Rh+ Newborn born to Rh- Mother.
60
Infliximab
ImmunoSuppressors Binding Proteins: 1) Infliximab 2) Etanercept Mechanism: => Bind to TNF-Alpha Uses: 1) Rheumatoid Arthritis 2) Crohn's Disease 3) Psoriasis
61
Etanercept
ImmunoSuppressors Binding Proteins: 1) Infliximab 2) Etanercept Mechanism: => Bind to TNF-Alpha Uses: 1) Rheumatoid Arthritis 2) Crohn's Disease 3) Psoriasis
62
Muromonab-CD3
ImmunoSuppressors Binding Protein Use: => Renal Transplant
63
Immune Globulin
ImmunoStimulant Natural Adjuvant Mechanism: (Prepared from pooled plasma) Uses: (Various ImmunoDeficiency States, Agammaglobulinemia)
64
Thalidomide
ImmunoStimulant Synthetic Toxicity: => Phocomelia!! (Absent/Short Limbs)
65
Interferon Alpha
ImmunoStimulant Cytokines Uses: => Various Neoplasms: 1) Kaposi's Sarcoma 2) Hairy Cell Leukemia
66
Interferon Beta-1b
ImmunoStimulant Cytokines Use: => Relapsing Multiple Sclerosis
67
Interleukin-2 | Immuno
ImmunoStimulant Cytokines Mechanism: => Produces Cytolytic Lymphocytes Against Tumor Cells Uses: 1) Renal Cell Carcinoma (RCC) 2) Metastatic Melanoma